Low-dose Radiotherapy and Chemoimmunotherapy in Nasopharyngeal Carcinoma With Liver Metastasis
Latest Information Update: 29 Jan 2025
Price :
$35 *
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary) ; Penpulimab (Primary)
- Indications Liver metastases; Nasopharyngeal cancer
- Focus Therapeutic Use
- Acronyms LiGHT
- 29 Jan 2025 New trial record